The price of CDXC is predicted to go up 14%, based on the high correlation periods with TRIP. The similarity of these two price pattern on the periods is 90.51%.
CDXC
TRIP
Up: 14%Similarity: 90.51%
CDXC Revenue Forecast
CDXC EPS Forecast
CDXC FAQs
What is CDXC revenue forecast for next quarter?
The market consensus for CDXC's revenue in the upcoming quarter is projected to be approximately $27.75M USD.
What is CDXC eps forecast for next quarter?
The market consensus for CDXC's eps in the upcoming quarter is projected to be approximately $0.02 USD.
Roth MKM raised the firm's price target on ChromaDex to $8 from $6 and keeps a Buy rating on the shares. The company's Q3 results handily beat estimates and demonstrate progress in pursuing new verticals targeted earlier in 2024, including Niagen+, Ataxia, and Parkinson's, the analyst tells investors in a research note. The firm adds that it has greater confidence now in the company's ability to capitalize on these opportunities.